AskTheDate.com
Back to calendar

Halozyme Therapeutics, Inc. (HALO) Earnings

HALO reports earnings on Tuesday, August 11, 2026

earnings report
August 11, 2026 · Before Market Open
Q2 2026
Est. EPS: $1.80
Actual EPS: $1.60
EPS surprise: 3.56%
Company overview
Market Cap$9.0B
PriceUSD 76.01
P/E27.34
EPS (TTM)2.78
52-week high82.26
52-week low55.64
SectorHealth Technology
IndustryBiotechnology
Employees423